A US start-up has given a patient a virus modified with artificial intelligence, with the goal of destroying some of the most antibiotic-resistant bacteria. The treatment marks a notable step for a research approach that is still at an early stage and that has drawn growing attention as drug-resistant infections spread.
The case was reported by Futura Sciences, the French science news outlet, which described the use of an AI-modified virus as a way to target bacteria that no longer respond to conventional antibiotics. The approach relies on viruses that attack bacteria, a concept that has been studied for decades and is often called phage therapy. Here, the viruses were altered with the help of artificial intelligence to better aim at the resistant strains.
Antibiotic resistance is widely described as an alarming problem for public health, because infections that once could be cured with common drugs are becoming harder and sometimes impossible to treat. Researchers and companies have been searching for new ways to tackle these pathogens, and bacteria-hunting viruses are one of the options being explored.
Several details remain unclear from the available reporting. The name of the start-up, the specific bacteria targeted and the exact type of virus used were not provided, and nothing has been said about the patient's condition, the dosing, the treatment results or the safety data. Without those elements, it is too early to judge how well the therapy works or what risks it may carry. Any broader conclusions will depend on further information and on the outcome of the treatment.